Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |